COMMENTARY Pairing LABAs and Inhaled Glucocorticoids: Safety Data Are Finally In William T. Basco, Jr., MD, MS Disclosures October 23, 2018 0 The Safety of Combination Asthma Therapy ...

Another study [3] was conducted by AstraZeneca at the request of the FDA to assess the safety of inhaled LABA drugs when added to inhaled glucocorticoid. Participants in this study were 12 years ...

A medium inhaled corticosteroid dose plus a long-acting beta agonist was found to be the most beneficial step-up treatment option for children with uncontrolled asthma, according to a meta ...

The study, which included data from 2003 to 2011 in Ontario, included individuals ages 66 years or older who met a validated case definition of COPD; there were 8,712 new users of LABA-inhaled ...

In a secondary analysis of serious asthma-related events, 0.6% of 18,006 patients in the inhaled-glucocorticoid group and 0.66% of 18,004 patients in the combination-therapy group had at last 1 ...

The FDA announced that long-acting beta agonists (LABAs) should never be used alone in the treatment of asthma. FDA analyses showed that use of these drugs is associated with an increased risk of ...

Long acting beta agonists (LABAs) are a family of inhaled medicines used to control asthma symptoms. LABAs include the medicines in Serevent and Foradil. LABAs are also available in combination ...

Please provide your email address to receive an email when new articles are posted on . This analysis spanned from 2016 to 2022. Nearly 50% of patients were initially prescribed LABA/inhaled ...

Use of a LABA alone without use of a long-term asthma control medication, such as an inhaled corticosteroid, is contraindicated (absolutely advised against) in the treatment of asthma.

There were 137,833 in the cohort: 30,829 started LAMA-LABA therapy and 107,004 started ICS-LABA therapy. Half of the patients were women (50.4%), and the mean age was 70.2 years.

LABA/LAMA is associated with a similar or lower risk of cardiovascular and cerebrovascular adverse events compared to treatment with LABA/inhaled corticosteroid. According to a new study published ...

Reference Sobieraj DM, Baker WL, Nguyen E, et al. Association of inhaled corticosteroids and long-acting muscarinic antagonists with asthma control in patients with uncontrolled, persistent asthma ...